Detection and characterization of antiviral-resistant viruses during the influenza season of 2024–25
During the high severity season of 2024–25, CDC with public health partners sequenced and analyzed genomes of >10,000 influenza viruses for antiviral resistance markers and provided information on susceptibility profile to all approved antiviral medications and on replicative fitness of representative drug-resistant vi...